Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

A Thakurta, A K Gandhi, M F Waldman, C Bjorklund, Y Ning, D Mendy, P Schafer, A Lopez-Girona, S Lentzsch, S A Schey, Y Calle, R Chelliah, R Z Orlowski, A Madan, H Avet-Loiseau, R Chopra

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1129-31
Number of pages3
Issue number5
Publication statusPublished - May 2014


  • Adjuvants, Immunologic
  • DNA-Binding Proteins
  • Humans
  • Mutation
  • Peptide Hydrolases
  • Thalidomide

Cite this